Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/2/13 → 8/8/13 |
Funding
- Children’s Hospital of Philadelphia
- Bayer HealthCare Pharmaceuticals, Inc.
AAML1031: A Phase III Randomized Trial for Patients with de novo AML using Bortezomib (NSC# 681239) and Sorafenib (BAY 43-9006, NSC# 724772) for Patients with High Allelic Ratio FLT2/ITD
- Hijiya, Nobuko (PD/PI)
Project: Research project